Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford is recruiting its third intake to study for a DPhil in Cancer Science commencing in October 2022.

Studentships are available for the DPhil in Cancer Science Programme, funded by Cancer Research UK. These are aimed at clinical trainees, medicine undergraduates and non-clinical researchers interested in cancer research projects based in University of Oxford research groups. All places are fully funded at the home rate, including salary/stipend, University and College fees, and a research consumables budget. International candidates are eligible but will need to source funding to meet the remaining fees.

There are several projects related to early detection and diagnosis available, including:

  • Bioengineered organoid models to investigate the interaction between driver mutations and cancer microenvironment in colorectal cancer progression – Professor Hagan Bayley
  • The role of RNA binding proteins in immune cell modulation in pre-invasive carcinoma – Dr Sarah Blagden
  • Application of multi-modal long-read single-cell sequencing to understand the role of clonality in Multiple Myeloma development – Dr Adam Cribbs
  • Novel approaches to circulating tumour cell detection and enrichment to combat bone metastasis – Dr Claire Edwards
  • The immune landscape of the pancreas during neoplastic transformation – Professor Eric O’Neill
  • Development of a cost-effective and rapid NMR-based blood test for the early detection of advanced polyps and colorectal cancer in patients with overlapping clinical symptoms – Dr Fay Probert
  • Mechanisms of Trisomy 21-induced B lymphoblastic leukaemia initiation in Down Syndrome – Professor Anindita Roy
  • Clinical utility and biological impact of platelet-restricted clonal haematopoiesis in cancer – Dr Susie Shapiro
  • Multimodal cell-free DNA epigenetic sequencing for early detection of pancreatic cancer – Dr Chunxiao Song
  • Non-Invasive metabolic imaging of liver cancer – Professor Ladislav Valkovic

Applications must be completed on the University of Oxford graduate application system by 3rd December 2021. Interviews will take place in January 2022. For more information, see the Oxford Cancer website.

Similar stories

Identifying early clinical features of myeloma in primary care

Research by Dr Karthik Ramasamy into the earlier recognition of myeloma symptoms in primary care aims to accelerate myeloma diagnosis.

Clinical academic research partnership to improve myeloma early diagnosis

Congratulations to Dr Karthik Ramasamy for his £270,000 award from the Medical Research Council.